Aarti Drugs Ltd (AARTIDRUGS)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 491.10
% Change: 2.93% (Prev Close: 477.10)

Volume: 2,67,757
% Change: 127.18% (Prev Volume: 1,17,862)

Delivery: 1,25,172
Delivery % : 46.75
% Change: 137.57% (Prev Delivery: 52,689)

Turnover: 1,308 Lacs
% Change: 134.90% (Prev Turnover: 557)

πŸ’Ή EOD Valuation

P/E Ratio: 23.91
P/B Ratio: 3.30
Market Cap: 4513 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AARTIDRUGS
Market Cap: 4317 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 576.30
52 Week Low: 312.00

All-Time High: 1026.95 Rs.
All-Time Low: 3.81 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
1.85% | 6.11% | 32.15% | -14.65% | 4.18%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 55.22%

Change (3Y | 1Y): -4.76% | -0.26%

Pledged %: 0.00%

FII Holding

FII Holding: 2.26%

Change (3Y | 1Y): 0.19% | 0.01%

DII Holding

DII Holding: 9.94%

Change (3Y | 1Y): 7.18% | 0.24%

Public Holding: 32.58%

🏦 Financial Strength

Debt to Equity: 0.45
Debt: 615.07 Rs. Cr.

Book Value: 148.91 Rs.
Current Ratio: 1.60
Interest Coverage: 7.13
Free Cash Flow: 67.47 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: -0.03%

Sales Growth Qtr (YOY | QoQ):
6.33% | -12.74%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
5.74% | -1.38% | -0.03%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 20.37%

Profit Growth Qtr (YOY | QoQ):
62.18% | -14.02%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
4.03% | -6.40% | 20.37%

EPS Rs.

EPS (TTM): 20.54 Rs.

EPS Qtr (Last Year | Latest):
3.62 Rs. | 5.86 Rs.

EPS Annual (Last Annual | Annual March):
18.65 Rs. | 18.29 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
4.31% | -6.17%

Net Profit Rs. Cr.

Net Profit (TTM): 188.79 Rs. Cr.

Net Profit (Annual - March): 168.10 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
33.27| 62.77 | 53.97

EBITDA Rs. Cr.

EBITDA (Quarter): 74.39 Rs. Cr.
EBITDA (Previous Yr Ql): 66.07 Rs. Cr.

EBITDA (Annual - March): 303.43 Rs. Cr.
EBITDA (Previous Annual): 325.05 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
2.59% | -4.09%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 12.23%

OPM Qtr (Previous | Current):
13.79% | 12.55%

OPM Annual (5 Yrs | Last Yr | March):
13.77% | 12.70% | 12.03%

Return on Equity %

ROE: 12.69%

ROE (5 Yrs | 3 Yrs | Last Yr):
18.24% | 13.76% | 13.87%

Return on Capital Employed %

ROCE: 12.93%

ROCE (5 Yrs | 3 Yrs | Last Yr):
19.67% | 14.46% | 15.00%

Return on Assets %

ROA (TTM): 6.71%

ROA (5 Yrs | 3 Yrs | Last Yr):
9.61% | 6.99% | 7.08%

PEG Ratio: -3.57
Dividend Yield: 0.21%

PE 3 Yrs: 25.42
PE 5 Yrs: 24.36

Dividend Yield: 0.21%

πŸ‘₯ Company

Aarti Drugs Ltd

AARTIDRUGS

Promoter Holding: %